President and Chief
Executive Officer
Medium- to long-term growth will be driven by our healthcare and school DX businesses.
Thank you very much for your continued support.
Our Group is committed to enhancing corporate value over the medium to long term by proactively investing in the healthcare business and the school DX business—both expected to drive future growth. Through these efforts, we aim to achieve sustained increases in revenue and profit in both business domains.
Overview of financial results for Q3 FY2026
Promoting Growth Investments in the Healthcare and School DX Businesses
Building a Foundation for Medium- to Long-Term Earnings Growth
For the third quarter of the fiscal year ending September 2026, consolidated net sales increased year on year to ¥23,277 million, while operating profit edged down to ¥2,273 million.
In the healthcare business, net sales increased, driven by growth in the number of pharmacies using cloud-based medication history services. The segment remained in the red, however, mainly due to higher system development costs for pharmacy DX and child-rearing DX, as well as expenses related to “LunaLuna Mirai Support.”
In the school DX business, net sales and profit rose substantially, reflecting initial development sales to public schools for the cloud-based school affairs support system “BLEND,” in addition to expanded sales to private schools.
Approah in FY2026
Given its significant future growth potential and its ability to become a stable, recurring business by building long‑term relationships with our customers, we will pursue various initiatives to grow both revenue and profit.
In the pharmacy DX business, we are developing a next-generation cloud-based receipt computer system that will serve as a core platform for improving operational efficiency at dispensing pharmacies. By combining AI and cloud technologies, we aim to streamline workflows from reception to payment and support efficient pharmacy operations with minimal staffing. We are making steady progress toward launch. We will also work to further improve profitability by promoting cloud-based support for dispensing pharmacies through a combination of the Group’s pharmacy DX products.
In the child-rearing DX business, we will further expand adoption of the “Boshimo” maternal and child health handbook app by municipalities, supported by the government’s promotion of digitalization in maternal and child health information. At the same time, we will accelerate the rollout of child-rearing DX services, primarily to municipalities that have already adopted the app, and develop this business into a core contributor to profitability in the healthcare business.
School DX business
We will continue promoting adoption at private schools, and, motivated by the government’s initiative to advance school administration DX within prefectural jurisdictions, we will actively engage in new orders from public schools and aim to achieve further growth in revenue and profit through an increase in the number of schools adopting our solutions.
Image of medium- to long-term profit
School DX business: short‑ to medium‑term contributor
Healthcare business: medium‑ to long‑term contributor
We view the school DX business as a short- to medium-term growth driver and the healthcare business as a medium- to long-term growth driver. Through the expansion of both businesses, we will continue working to enhance corporate value.
We hope that we can continue to count on your support as we pursue our initiatives.
August, 2026